Despite challenges of decision making for unrepresented patients, few laws or policy statements offer solutions. This article offers 5 key things to do.
AMA J Ethics. 2019;21(7):E582-586. doi:
10.1001/amajethics.2019.582.
Physicians, committees, and guardians all make decisions for unrepresented patients in the US. This article considers a “tiered” approach as an alternative.
AMA J Ethics. 2019;21(7):E587-593. doi:
10.1001/amajethics.2019.587.
The stigma associated with HIV has diminished with its spread among the heterosexual population and the development of effective treatments. This normalization may justify assuming a more traditional public health perspective about mandatory prenatal screening.
The law and medical ethics demand reconsideration of inflexible technical standards that are vulnerable to litigation under disability discrimination laws.
AMA J Ethics. 2016;18(10):1010-1016. doi:
10.1001/journalofethics.2016.18.10.hlaw1-1610.
After the Indiana HIV outbreak in 2015, Congress partially repealed the ban on needle exchange programs, providing funding for operations but not syringes.
AMA J Ethics. 2016;18(3):252-257. doi:
10.1001/journalofethics.2016.18.3.hlaw1-1603.
People with mental illness or a degenerative mental disease have special protections under the law when entering into contracts or other binding documents.
A review of a landmark case that determined why and under what circumstances antipsychotic medications can be administered to incarcerated patients with mental illness against their will.
Clinical trials for the blood substitute PolyHeme exposed the possibility for ambiguous interpretation of the FDA’s waiver of informed consent for emergency research.
Parents' ability to make medical decisions for their children can be limited by state law if it is determined that the child's best interest is not being met.